Your browser doesn't support javascript.
loading
Current uptake and barriers to wider use of the International Ovarian Tumor Analysis (IOTA) models in Dutch gynaecological practice.
Lems, E; Leemans, J C; Lok, C A R; Bongers, M Y; Geomini, P M A J.
Affiliation
  • Lems E; Máxima Medical Centre in Veldhoven, De Run 4600, 5504 DB Veldhoven, the Netherlands; Maastricht University Medical Centre and Research School Grow, Maastricht, P. Debyelaan 25, 6229 HX, the Netherlands. Electronic address: esther.lems@mmc.nl.
  • Leemans JC; Máxima Medical Centre in Veldhoven, De Run 4600, 5504 DB Veldhoven, the Netherlands.
  • Lok CAR; Department of Gynaecologic Oncology, Centre for Gynaecologic Oncology Amsterdam, the Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Bongers MY; Máxima Medical Centre in Veldhoven, De Run 4600, 5504 DB Veldhoven, the Netherlands; Maastricht University Medical Centre and Research School Grow, Maastricht, P. Debyelaan 25, 6229 HX, the Netherlands.
  • Geomini PMAJ; Máxima Medical Centre in Veldhoven, De Run 4600, 5504 DB Veldhoven, the Netherlands.
Eur J Obstet Gynecol Reprod Biol ; 291: 240-246, 2023 Dec.
Article in En | MEDLINE | ID: mdl-37939622
ABSTRACT

OBJECTIVE:

Correct referral of women with an ovarian tumor to an oncology department remains challenging. The International Ovarian Tumor Analysis (IOTA) consortium has developed models with higher diagnostic accuracy than the alternative Risk of Malignancy Index (RMI). This study explores the uptake of the IOTA models in Dutch hospitals and factors that impede or promote implementation. Optimal implementation is crucial to improve pre-operative classification of ovarian tumors, which may lead to better patient referral to the appropriate level of care. STUDY

DESIGN:

In February 2021, an electronic questionnaire consisting of 37 questions was sent to all 72 hospitals in the Netherlands. One pre-selected gynaecologist per hospital was asked to respond on behalf of the department.

RESULTS:

The study had a response rate of 93% (67/72 hospitals). All respondents (100%) were familiar with the IOTA models with 94% using them in practice. The logistic regression 2 (LR2)-model, Simple ultrasound-based rules (SR) and Assessment of Different NEoplasias in the adneXa (ADNEX) model were used in respectively 40%, 67% and 73% of these hospitals. Respondents rated the models overall with an 8.2 (SD 1.8), 8.3 (SD 1.6) and 8.9 (SD 1.3) respectively for LR2, SR and ADNEX on a scale from 1 to 10. Moreover, 89% indicated to have confidence in the results of the IOTA models. The most important factors to improve further implementation are more training (43%), research on sensitivity, specificity and cost-effectiveness in the Dutch health care system (27%), easier usability (24%) and more consultation time (19%).

CONCLUSION:

The IOTA ultrasound models are adopted in the majority of Dutch hospitals with the ADNEX model being used the most. While Dutch gynecologists have a strong familiarity and confidence in the models, the uptake varies in reality. Areas that warrant improvement in the Dutch context are more uniformity, education and more research. These findings can be helpful for other countries considering adopting the IOTA models.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Adnexal Diseases Limits: Female / Humans Language: En Journal: Eur J Obstet Gynecol Reprod Biol Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Adnexal Diseases Limits: Female / Humans Language: En Journal: Eur J Obstet Gynecol Reprod Biol Year: 2023 Document type: Article
...